2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$16.78+$0.13 (+0.77%)
Price as of Aug 21, 2026 7:56 PM EDT- $2.2BMarket Cap
- 35.70%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$16.78+$0.13 (+0.77%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.65 | ||
Change | -$0.62 (-3.59%) | ||
Open | $17.20 | ||
High | $17.32 | ||
Low | $16.63 | ||
Previous Close | $17.27 | ||
Volume | 1,248,763 | ||
30-Day Average Volume | 1,225,855 | ||
1-Week Change | 7.63% | ||
1-Month Change | 6.46% | ||
1-Year Change | 35.70% | ||
3-Year Change | 74.35% | ||
5-Year Change | 22.07% | ||
Fundamentals | |||
Shares Outstanding | 133.1M | ||
Total Assets | $792.3M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $79.4M | ||
Net Income | $37.4M | ||
Free Cash Flow | $52.6M | ||
EBIT | $48.8M | ||
EBITDA | $53.6M | ||
Net Working Capital | $441.4M | ||
EPS | $0.28 | ||
Enterprise Value/EBITDA | 38 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 4 | ||
P/E | 59 | ||
PEG | 5 | ||
Price/Free Cash Flow | 42 | ||
Price/Operating Cash Flow | 42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue